Replies to post #7934 on Innovus Pharmaceuticals Inc. (fka INNV)

[Honeycomb777]

So many questions Sweet. I can tell you that the ads have really ramped up in Q1 2017 - as I have shown countless examples on this message board.

Ads went out for 4 or 5 of our best selling products in small, medium, and large newspapers and publications across the country. We know our margins, approximate ad costs, and locations/circulation. We simply are awaiting the hit/take rates from the readers.

It's very hard to think we would break even or lose money given average take rates based on historical marketing stats for newsprint. INNV really pushed UriVarx, Vesele, and Sensum+ in Q1 with full-page ads. Recalmax and BH Testosterone too, but to a lesser extent.

Again, how is that $2M/yr. deal going to be booked or has it ? BIG Question IMO